Alterity Therapeutics Ltd (ATHE) insider trading
Every open-market stock purchase and sale by Alterity Therapeutics Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Peter Ashley Marks (Director) and 1 other bought $47.6K in the last 90 days.
Last 12 months: insiders bought $47.6K (2 buys) and sold $0 (0 sales). Last close $4.11 on Sep 10, 2026.
Recent ATHE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 31, 2026 | Peter Ashley Marks (Director) | Bought | $23.8K |
| Aug 31, 2026 | David Allen Stamler (CEO) | Bought | $23.8K |
| Jun 15, 2026 | Lawrence Bernard Gozlan (Director) | Bought (not open market) | — |
| Jun 15, 2026 | Julian Michael Babarczy (Director) | Bought (not open market) | — |
Who's trading ATHE
- Peter Ashley Marks, Director: bought $23.8K (1 buy), last Aug 31, 2026
- David Allen Stamler, CEO: bought $23.8K (1 buy), last Aug 31, 2026
- Julian Michael Babarczy, Director: other filings, last Jun 15, 2026
- Lawrence Bernard Gozlan, Director: other filings, last Jun 15, 2026
Get free alerts when an insider at Alterity Therapeutics Ltd files a new trade →